Clinical Trial Update: Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pioglitazone to glyburide in adults with type 2 diabetes mellitus and mild cardiac disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glyburide (glyburide)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED